The presented findings indicate that the determination in the blood or saliva of antipyrine concentration kinetics as well as the profile and the ratio of the products of its hydroxylation in the urine makes it possible to evaluate under clinical conditions the activity of the hydroxylating (monooxygenase) system of the human liver and, consequently, the state of its main therapeutic-metabolizing function that is undoubtedly important for the optimization of pharmacotherapy.

Download full-text PDF

Source

Publication Analysis

Top Keywords

[evaluation liver
4
liver monooxygenase
4
monooxygenase function
4
function kinetics
4
kinetics antipyrine
4
antipyrine metabolites
4
metabolites liquid
4
liquid media
4
media body]
4
body] presented
4

Similar Publications

Background And Aim: Zinc oxide and copper oxide nanoparticles are known for their promising biological activities. This study aims to synthesize zinc oxide nanoparticles and copper-doped zinc oxide nanoparticles to harness the combined cytotoxic and anticancer effects of them in vitro and in vivo studies.

Methods: Zinc oxide nanoparticles, both doped and undoped, were synthesized using a chemical co-precipitation method.

View Article and Find Full Text PDF

HCV and HBV genotypes: vital in the progression of HCV/ HBV co-infection.

BMC Gastroenterol

January 2025

Department of Community Health Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, 11433, Saudi Arabia.

Background: Viral hepatitis is the major contributor to liver cirrhosis and hepatocellular carcinoma (HCC). Studies indicated that the co-infection of hepatitis C and hepatitis B virus also prompts liver damage progression. Therefore, in the present study, the prevalence of HCV-HBV co-infection and the impact of HCV-HBV co-infection on the progression of liver damage was evaluated amongst the HCV-infected patients in Pakistan.

View Article and Find Full Text PDF

Acute kidney injury is associated with liver-related outcomes in patients with hepatitis B virus infection: a retrospective cohort study.

BMC Nephrol

January 2025

Division of Nephrology, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, 1838 N Guangzhou Ave, Guangzhou, 510515, China.

Background: The effects of acute kidney injury (AKI) on liver-related outcomes in patients with hepatitis B virus (HBV) infection remain unclear. The study aimed to evaluate the association between AKI with liver-related mortality and complications in patients with HBV infection.

Methods: The multicenter, retrospective cohort study included Chinese adults with HBV infection from 24 regional central hospitals between January 2000 and December 2022.

View Article and Find Full Text PDF

How does the knowledge level of physicians and nurses working at primary health centers affect their preference for oral contraceptives in an inland Turkish province?

BMC Prim Care

January 2025

School of Medicine, Department of Obstetrics and Gynecology, Afyonkarahisar Health Sciences University, Zafer Sağlık Külliyesi Dörtyol Mahallesi 2078 Sokak No: 3, Afyonkarahisar, Turkey.

Background: Standardizing the knowledge of health care givers and eliminating their misconceptions would help to achieve optimal service for contraception. This study aims to evaluate the knowledge levels of physicians and nurses working at primary health care centers about the oral contraceptive pill (OCP) use.

Methods: This is a cross-sectional review of 306 professional care givers (117 physicians and 189 nurses) who are working at primary health care centers.

View Article and Find Full Text PDF

Silibinin alleviates acute liver failure by modulating AKT/GSK3β/Nrf2/GPX4 pathway.

Naunyn Schmiedebergs Arch Pharmacol

January 2025

Jiangsu Key Laboratory of TCM Evaluation and Translational Research, Department of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 639 Longmian Road, Nanjing, 211198, P. R. China.

Silibinin (Sil) is a major bioactive component of silymarin, extracted from the fruit and seeds of Silybum marianum. Silibinin meglumine (SM) is a water-soluble derivative of silibinin that has shown significant potential in liver fibrosis. However, the potential effects and underlying mechanisms of SM on acute liver failure (ALF) are still not fully understood.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!